Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF) Announces CSPA Group’s Completed Packaging of the CBD

Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF), (Frankfurt: LD6, WKN: A14XHT) (“LDS” or the “Company”) is proud to announce that Lifestyle Delivery Systems Inc.’s wholly-owned subsidiary, CSPA Group, Inc., has completed the initial packaging of the fourth generation of CBD CannaStrips^TM for the Californiamarket. The packaged CBD CannaStrips^TM will now be sent to an independent laboratory for California State testing. This is the final requirement on all manufactured cannabis products before they are eligible for distribution and sale. The latest formulation has improved taste and faster bio-availability. The completed CBD version is a 10mg CBD strip with less than 2% THC. All of the CBD versions will have a full spectrum of Cannabinoids, Terpenes and Flavonoids to promote all possible entourage effects.

The Company’s CEO, Brad Eckenweiler, commented, “This product has been long awaited and is possibly the most significant product of the LDS mission for customers looking for safe contaminant-free cannabis products without the issues of smoking or ingesting cannabis. We developed CannaStrips^TM in the hope that cannabinoids could help reduce cancer treatment symptoms without smoking or ingesting cannabis in its harshest forms.  The CannaStrips^TM delivery system accomplishes this objective seamlessly without offending or affecting others, discreetly, quickly, and tastefully.”

All of the CannaStrips^TM products come with a laboratory certification of the cannabinoids as well as terpenes and flavonoids in the informational pamphlet included with each CannaStrips^TM 10 pack. The customers will always know the precise ingredients in CannaStrips^TM. The Company will keep its shareholders apprised of the progress regarding CannaStrips^TM and their availability at retailers in California.

About Lifestyle Delivery Systems Inc.

Lifestyle Delivery Systems Inc. is a technology company that licenses its technology to a state-of-the-art production and packaging facility located in Southern California. The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to any other form of delivery but also allows for inclusion of a wide spectrum of ingredients from over the counter medications to homeopathic, nutraceutical, vitamins and supplements. The technology provides a new way to accurately meter the dosage and assure the purity of selected product. From start to finish, the production process, based on the Company’s technology, tests for quality and composition of all the ingredients used in each and every strip which results in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler
CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:
investor.relations@lifestyledeliverysystem.com
1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.